Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Horizon Pharma
Horizon Pharma
Amgen's new Horizon products bolster top line despite continued Tepezza struggles
Fierce Pharma
Fri, 05/3/24 - 11:23 am
Amgen
Horizon Pharma
Krystexxa
Tepezza
Roche, Horizon lead way for pharma reputation among rare disease patient groups
Medical Marketing and Media
Wed, 08/23/23 - 05:49 pm
Roche
Horizon Pharma
reputation
rare disease
Large pharmas probe takeover of Horizon Therapeutics
BioPharma Dive
Wed, 11/30/22 - 10:58 am
Horizon Pharma
M&A
JNJ
Sanofi
Amgen
Horizon charts massive biologics expansion in Ireland, where it'll add 350 new jobs
Fierce Pharma
Mon, 08/29/22 - 10:51 am
Horizon Pharma
biologics
Ireland
hirings
drug manufacturing
In a quiet year for takeouts, who was buying?
EP Vantage
Fri, 01/28/22 - 09:54 am
M&A
Jazz Pharmaceuticals
Horizon Pharma
MorphoSys
Horizon switched up strategy for Tepezza launch, moving quickly to DTC to reach eye disease patients
Fierce Pharma
Tue, 01/19/21 - 10:44 am
Horizon Pharma
thyroid eye disease
Tepezza
drug launches
DTC
FDA in-house review spotlights an issue with one of Horizon's endpoints but notes efficacy for lead drug
Endpoints
Thu, 12/12/19 - 11:01 am
FDA
Horizon Pharma
clinical trials
teprotumumab
thyroid eye disease
Horizon Pharma’s Thyroid Eye Disease Treatment Could Become a Blockbuster, Analyst Predicts
BioSpace
Mon, 04/29/19 - 09:37 pm
Horizon Pharma
thyroid eye disease
teprotumumab
The Week Ahead In Biotech: Conferences, Clinical Trial Readouts, Earnings And IPOs
Yahoo/Benzinga
Mon, 04/22/19 - 10:34 am
Concert Pharmaceuticals
Horizon Pharma
Edwards Lifesciences
Zimmer Biomet
Genfit
Precision Biosciences
Boston Scientific
AbbVie
Alexion
Bristol-Myers Squibb
Baxter
Biomarin
AtriCure
Biogen
Seattle Genetics
IPOs
earnings
After thyroid eye drug scores in PhIII test, Horizon Pharma readies marketing application
Endpoints
Fri, 03/1/19 - 09:29 am
thyroid eye disease
Horizon Pharma
teprotumumab
Genentech, Horizon Earn Spots on List of ‘Companies That Care’
BioSpace
Sat, 07/28/18 - 12:39 pm
Genentech
Horizon Pharma
employees
Horizon Pharma Receives Two Additional Patents on Ravicti
CP Wire
Tue, 05/8/18 - 10:21 am
Horizon Pharma
Ravicti
Horizon Pharma Receives Two Additional Patents on Ravicti
Tue, 05/8/18 - 09:58 am
Horizon Pharma
Ravicti
Physicians And Patients Finally Avoiding Horizon's Expensive, Low-Value Pain Drugs Duexis And Vimovo
Forbes
Thu, 03/15/18 - 09:33 pm
physicians
patients
Horizon Pharma
drug pricing
vivmo
Duexis
painkillers
Specialty pharmacy scrutiny hits again with state's focus on Horizon meds
Fierce Pharma
Sat, 12/9/17 - 02:26 pm
specialty pharmacies
Horizon Pharma
Express Scripts
Valeant Pharmaceuticals
Krystexxa shows signs of life as Horizon keeps pushing sales force expansion
Fierce Pharma
Wed, 10/11/17 - 11:20 am
Krystexxa
Horizon Pharma
drug reps
gout
Horizon CEO Tim Walbert knows patients because he is one
Medical Marketing and Media
Wed, 08/23/17 - 11:39 am
Tim Walbert
Horizon Pharma
Pharma CEOs
autoimmune disease
Duexis
patients
Horizon dives into eye treatments with River Visions acquisition
BioPharma Dive
Sun, 05/14/17 - 12:56 pm
Horizon Pharma
River Visions
M&A
eye health
Horizon Pharma buys River Vision and its fast-tracked eye med for $145M
Fierce Biotech
Mon, 05/8/17 - 10:07 pm
Horizon Pharma
River Vision
eye health
teprotumumab
thyroid eye disease
Tapping into the rare disease market
BioPharma Dive
Fri, 03/10/17 - 09:00 pm
Rare Diseases
Incyte
Horizon Pharma
Lundbeck
Pages
1
2
3
4
5
6
next ›
last »